期刊文献+

子宫内膜浆液性癌患者输卵管伞端组织的病理特征研究 被引量:2

Pathologic features of fallopian tubal fimbriae in patients with endometrial serous carcinoma
原文传递
导出
摘要 目的 通过研究子宫内膜浆液性癌(ESC)患者输卵管伞端组织的病理特征,初步探讨ESC的发生与输卵管伞端组织病变的关系.方法 收集北京大学人民医院1999年至2013年间收治的所有典型ESC患者共30例(包括Ⅰ期13例,Ⅱ期2例,Ⅲ期15例),取其石蜡包埋的典型ESC组织、双侧输卵管伞端组织.(1)通过HE染色切片观察ESC患者的输卵管伞端组织的病理特征,分析输卵管伞端上皮内病变特点、程度及其与ESC期别的关系.(2)利用免疫组化法检测ESC患者的内膜癌组织与其输卵管伞端组织中p53、人类表皮生长因子2(HER2/neu)、高迁移率族蛋白A2(HMGA2)、膜联蛋白Ⅳ(ANX-Ⅳ)蛋白的表达,并分析其相关性.结果 (1)30例ESC患者中,15例(50%)合并输卵管伞端上皮的病变,包括输卵管浆液性癌9例(Ⅲa期5例,Ⅲc期4例),输卵管上皮内癌(STIC)2例(Ⅰa期、Ⅰb期各1例),输卵管上皮增生2例(Ⅰa期),输卵管浆液性癌合并STIC 1例(Ⅲa期),输卵管浆液性癌合并输卵管上皮增生1例(Ⅲc期).(2)ESC患者的内膜癌组织中p53蛋白的阳性表达率为87%(26/30),其输卵管伞端组织中为30%(9/30),两者比较,差异有统计学意义(P=0.001).ESC患者的内膜癌组织与其输卵管伞端组织中p53蛋白的表达呈中度正相关(r=0.506,P=0.022).(3)ESC患者的内膜癌组织中ANX-Ⅳ蛋白的阳性表达率为83%(25/30),其输卵管伞端组织中为20%(6/30);内膜癌组织中HER2/neu蛋白的阳性表达率为70%(21/30),其输卵管伞端组织中为23%(7/30);内膜癌组织中HMGA2蛋白的阳性表达率为83%(25/30),其输卵管伞端组织中为20%(6/30).上述3个蛋白在内膜癌组织与其输卵管组织中分别比较,差异均有统计学意义(P〈0.05);但上述3个蛋白在ESC患者的内膜癌组织与其输卵管伞端组织中的表达均无相关性(P〉0.05).结论 Ⅰ期ESC患者的输卵管伞端合并STIC,提示STIC与ESC的发生可能存在一定的关系;在内膜癌与其输卵管组织中,p53蛋白的表达存在相关性,而HER2/neu、ANX-Ⅳ、HMGA2的表达无相关性. Objective To discuss the potential relationship between endometrial serous carcinoma (ESC) and tubal epithelial lesions by pathologic examination of fallopian tubes with ESC. Methods A total of 30 cases of typical ESC were reexamined and chosen by the pathologist. In each case, bilateral fallopian tubes were submitted to examination of pathologic morphology and immunostaining for p53, annexin Ⅳ(ANX-Ⅳ), human epidermal growth factor receptor 2(HER2)/neu, and high-mobility group protein A2 (HMGA2). Results Fallopian tubal epithelial lesions were found in 15 cases, including 9 cases tubal serous carcinoma, 2 cases serous tubal intraepithelial carcinoma (STIC) and 2 cases epithelial hyperplasia. Both sides of tubal serous carcinoma and STIC were found in 1 case. The results showed the positive expression for p53 in 26(87%)out of 30 endometrial malignant specimens tissues and 9(30%)tubal tissues samples (P〉0.05). Twenty-five(83%)endometrial malignant specimens tissues and 6(20%)tubal tissues samples showed the positive expression of ANX-Ⅳ. Twenty-one(70%)endometrial malignant tissues and 7(23%) tubal tissues showed the positive expression of HER2/neu. Twenty-five(83%) endometrial malignant tissues and 6(20%)tubal tissues showed the positive expression of HMGA2. While, there were significant differences among the expression of three proteins between endometrium and the fallopian tube site (all P〈0.05). Conclusions STIC may be associated with the occurrence of ESC. The expression of p53 was positively correlated between the fallopian tube and the endometrium. ANX-Ⅳ,HER2/neu and HMGA2 were extensively expressed in ESC.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2015年第10期757-761,共5页 Chinese Journal of Obstetrics and Gynecology
关键词 子宫内膜肿瘤 乳头状 输卵管肿瘤 肿瘤抑制蛋白质P53 受体 erbB-2 肽碎片 HMGA2蛋白 膜联蛋白质类 Endometrial neoplasms Carcinoma, papillary Fallopian tube neoplasms Tumor suppressor protein p53 Receptor, erbB-2 Peptide fragments HMGA2 protein Annexins
  • 相关文献

参考文献12

  • 1Vang R, Shihle M, Kurman RJ. Fallopian tube precursors of ovarianlow-andhigh-gradeserousneoplasms[J].Histopathology, 2013,62(1) : 44-58.
  • 2Tang S, Onuma K, Deb P, et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases[J]. Int J Gynecol Pathol, 2012, 31 (2): 103-110.
  • 3Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship[J]. Am J Surg Pathol, 2007, 31(2):161-169.
  • 4Jarboe EA, Miron A, Carlson JW, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance[J]. Int J Gynecol Pathol, 2009, 28(4):308-315.
  • 5Jia L, Liu Y, Yi X, et al. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its preeaneer nature for endometrial serous carcinoma[J]. Clin Cancer Res, 2008, 14(8):2263-2269.
  • 6Sakuragi N, Watari H, Ebina Y, et al. Functional analysis of P53 gene and the Prognosis impact of dominant-negative P53 mutation in endometrial cancer[J]. Int J Cancer, 2005, 116(4): 514-519.
  • 7Vang R, Shih IM, Kurman RJ. Fallopian tube precursors of ovarian low- and high- grade serous neoplasms[J]. Histopathology, 2013, 62(1):44-58.
  • 8Jarboe EA, Miron A, Carlson JW, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: Frequency and potential significance [J]. Int J Gynecol Pathol, 2009, 28(4):308-315.
  • 9Tolcher MC, Swisher EM, Medeiros F, et al. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma[J]. Int J Gynecol Pathol, 2015, 34(1):57-64.
  • 10Slomovitz BM, Broaddus RR, Burke TW, et al. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma[J]. J Clin Oncol, 2004, 22(15):3126-3132.

同被引文献29

  • 1乐杰.妇产科学[M].6版.北京:人民卫生出版社,2009:125.
  • 2Tang S, Onuma K, Deb P, et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases[J]. Int J Gynecol Pathol, 2012, 31(2):103-110. DOI: lO.1097/PGP.ObO13e31822ea955.
  • 3Vang R, IeM S, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms[J]. Histopathology, 2013, 62(1):44-58. DOI: 10.1111/his.12046.
  • 4Ayeni TA, Bakkum-Gamez JN, Mariani A, et al. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma[J]. Gynecol Oncol, 2013, 128(1): 71-76. DOI: lO.lO16/j.ygyno.2012.10.025.
  • 5Stewart C J, Doherty DA, Havlat M, et al. Transtubal spread of endometrial carcinoma: correlation of intra-luminal turnout cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis[J]. Pathology, 2013, 45(4):382-387. DOI: 10.1097/PAT.0b013e328360b6e7.
  • 6Felix AS, Brinton LA, McMeekin DS, et al. Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial[J]. J Natl Cancer Inst, 2015, 107(9).pii:djv158. DOI: 10.1093/ jnci/djv158.
  • 7Chang YN, Zhang Y, Wang YJ, et al. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis[J]. Fertil Steril, 2011, 96(4):957-961. DOI: 10.1016/j.fertnstert.2011.07.1146.
  • 8Li M, Li M, Zhao L, et al. Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma[J]. Int J Gynecol Cancer, 2016, 26(6):1092-1097. DOI: 10.1097/IGC.0000000000000727.
  • 9Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths[J]. Am J Obstet Gynecol, 2008, 198(2):218.el-6. DOI: 10.1016/j.ajog.2007.08.075.
  • 10Fader AN, Boruta D, Olawaiye AB, et al. Uterine papillary carcinoma: epidemiology, pathogenesis and management[J]. Curr Opin Obstet Gynecol, 2010, 22(1):21-29. DOI: 10.1097/GCO.0b013e328334d8a3.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部